Evidence map›Paper›PMID 22081140›Full record

ArticleEMBO reports2011

Dictyostelium chemotaxis: essential Ras activation and accessory signalling pathways for amplification.

Arjan Kortholt, Rama Kataria, Ineke Keizer-Gunnink, Wouter N Van Egmond, Ankita Khanna, Peter J M Van Haastert

Abstract read
In one paragraph

Article in EMBO reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Loss of Copine D Leads to Ras Activation inbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Two endogenousProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sex-Based Differences in Human Neutrophil Chemorepulsion.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  14. Article
  15. Article
  16. Forty-five years of cGMP research inMolecular biology of the cell · 2021
    Review
  17. Review
  18. UsingFrontiers in cell and developmental biology · 2021
    Review
  19. Using Live-Cell Imaging and Synthetic Biology to Probe Directed Migration inFrontiers in cell and developmental biology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arjan KortholtDepartment of Cell Biochemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
Rama Kataria
Ineke Keizer-Gunnink
Wouter N Van Egmond
Ankita Khanna
Peter J M Van Haastert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central to chemotaxis is the molecular mechanism by which cells exhibit directed movement in shallow gradients of a chemoattractant. We used Dictyostelium mutants to investigate the minimal requirements for chemotaxis, and identified a basal signalling module providing activation of Ras at the leading edge, which is sufficient for chemotaxis. The signalling enzymes PI3K, TorC2, PLA2 and sGC are not required for Ras activation and chemotaxis to folate or to steep gradients of cAMP, but they provide a memory of direction and improved orientation of the cell, which together increase the sensitivity about 150-fold for chemotaxis in shallow cAMP gradients.

Indexed as

ChemotaxisSignal TransductionCyclic AMPDictyosteliumEnzyme ActivationFolic AcidGreen Fluorescent ProteinsModels, Biologicalras ProteinsRecombinant Fusion ProteinsCyclic AMPFolic AcidGreen Fluorescent Proteinsras ProteinsRecombinant Fusion Proteins

Identifiers

PMID22081140
PMCPMC3245697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.